Press release
Gastrointestinal Stromal Tumors Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies by DelveInsight
Gastrointestinal Stromal Tumors pipeline
Gastrointestinal stromal tumors (GISTs) are rare neoplasms of the gastrointestinal tract associated with high rates of malignant transformation. Most GISTs present asymptomatically. They are best identified by computed tomography (CT) scan and most stain positive for CD117 (C-Kit), CD34, and/or DOG-1. There have been many risk stratification classifications systems which are calculated based on tumor size, mitotic rate, location, and perforation.
"Gastrointestinal Stromal Tumors Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Gastrointestinal Stromal Tumors Market.
The Gastrointestinal Stromal Tumors Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
To know more about the Gastrointestinal Stromal Tumors Pipeline report, click here: https://www.delveinsight.com/report-store/gastrointestinal-stromal-tumor-gist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's Gastrointestinal Stromal Tumors Report covers around 28+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Gastrointestinal Stromal Tumors Drugs Under Different Phases of Clinical Development Include:
• Famitinib: Jiangsu Hengrui Medicine
• Nilotinib: Novartis
• THE-630: Theseus Pharmaceuticals
• DS 6157: Daiichi Sankyo Company
Further Gastrointestinal Stromal Tumors product details are provided in the report. Download the Gastrointestinal Stromal Tumors report to learn more about the emerging Gastrointestinal Stromal Tumors therapies at: https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Gastrointestinal Stromal Tumors Pipeline Analysis
The Gastrointestinal Stromal Tumors report provides insights into:
The report provides detailed insights about companies that are developing therapies for the treatment of Gastrointestinal Stromal Tumors with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Gastrointestinal Stromal Tumors Treatment.
Gastrointestinal Stromal Tumors key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Gastrointestinal Stromal Tumors Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Gastrointestinal Stromal Tumors market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Request for Sample PDF Report for Gastrointestinal Stromal Tumors pipeline assessment- https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key companies in the Gastrointestinal Stromal Tumors Therapeutics Market:
Some of the Gastrointestinal Stromal Tumors companies working in the market are Jiangsu Hengrui Medicine, Novartis, Theseus Pharmaceuticals, Daiichi Sankyo Company, Cogent Biosciences, Advenchen Laboratories, Chia Tai Tianqing Pharmaceutical Group, AB Science, Immunic#m AB, Bristol-Myers Squibb, Hanmi Pharmaceutical Company Limited, GlaxoSmithKline, Ascentage Pharma, Takeda, Array BioPharma, Plexxikon, Arog Pharmaceuticals, Xencor.Inc, DNAtrix.Inc., Onyx Pharmaceuticals, Exelixis, Allarity Therapeutics, Theseus Pharmaceuticals and Others.
Request for Sample PDF Report to know more about Gastrointestinal Stromal Tumors drugs and therapies - https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Gastrointestinal Stromal Tumors Current Treatment Patterns
4. Gastrointestinal Stromal Tumors - DelveInsight's Analytical Perspective
5. Gastrointestinal Stromal Tumors Therapeutic Assessment
6. Gastrointestinal Stromal Tumors Late Stage Products (Phase-III)
7. Gastrointestinal Stromal Tumors Mid-Stage Products (Phase-II)
8. Gastrointestinal Stromal Tumors Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Gastrointestinal Stromal Tumors Products
11. Dormant Gastrointestinal Stromal Tumors Products
12. Gastrointestinal Stromal Tumors Discontinued Products
13. Gastrointestinal Stromal Tumors Product Profiles
14. Key Companies in the Gastrointestinal Stromal Tumors Market
15. Key Products in the Gastrointestinal Stromal Tumors Therapeutics Segment
16. Dormant and Discontinued Products
17. Gastrointestinal Stromal Tumors Unmet Needs
18. Gastrointestinal Stromal Tumors Future Perspectives
19. Gastrointestinal Stromal Tumors Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report for Gastrointestinal Stromal Tumors clinical trials advancements- https://www.delveinsight.com/sample-request/gastrointestinal-stromal-tumor-gist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Hpv-Induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Advanced Hepatocellular Carcinoma With Cpb Liver Cirrhosis Market: https://www.delveinsight.com/report-store/advanced-hepatocellular-carcinoma-with-cpb-liver-cirrhosis-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Bone Grafts And Substitutes Market: https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Age Related Vision Dysfunction Market: https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Stromal Tumors Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies by DelveInsight here
News-ID: 2748585 • Views: …
More Releases from DelveInsight Business Research
Myocardial Infarction Pipeline Assessment, 2024 Updates | In-depth Insights into …
Myocardial Infarction pipeline constitutes 45+ key companies continuously working towards developing 50+ Myocardial Infarction treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Myocardial Infarction Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myocardial Infarction Market.
The Myocardial Infarction Pipeline report embraces in-depth commercial and clinical assessment of the…
Acute Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Pain pipeline constitutes 25+ key companies continuously working towards developing 25+ Acute Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Acute Pain Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Acute Pain Market.
The Acute…
Diabetic Retinopathy Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Retinopathy pipeline constitutes 50+ key companies continuously working towards developing 55+ Diabetic Retinopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Diabetic Retinopathy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Retinopathy Market.
The Diabetic…
T-cell receptor (TCR) Therapy Pipeline Drugs Analysis Report, 2024: FDA Approval …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, T-cell receptor (TCR) Therapy pipeline constitutes key companies continuously working towards developing T-cell receptor (TCR) Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"T-cell receptor (TCR) Therapy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the T-cell…
More Releases for Gastrointestinal
Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/
Gastrointestinal stents are used as an effective alternate to perform…
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Gastrointestinal Stents Market: Rising Incidences of Gastrointestinal Diseases t …
The world market for gastrointestinal stents has been assessed by a recent publication by Transparency Market Research. The market has been characterized with the presence of a few market players and is considered to be highly consolidated. The world gastrointestinal stents market is dominated by Boston Scientific Corporation and it held around 66.2% share of the total market in the year 2016. The same market, however, features fragmentation owing to…
Gastrointestinal Stents Market: Rising Incidences of Gastrointestinal Diseases t …
The world market for gastrointestinal stents has been assessed by a recent publication by Transparency Market Research. The market has been characterized with the presence of a few market players and is considered to be highly consolidated. The world gastrointestinal stents market is dominated by Boston Scientific Corporation and it held around 66.2% share of the total market in the year 2016. The same market, however, features fragmentation owing to…
Gastrointestinal Drugs Market - Upcoming Trends
The global gastrointestinal drugs market is consolidated with the top three players accounting for a whopping 61% of the market collectively in 2016. These three players are: Valeant Pharmaceuticals Inc., Janssen Biotech Inc., and Takeda Pharmaceutical. While the market is moderately competitive at present, future holds much competitiveness among players and thus, the degree of competition is expected to be increase in the forecast period, states a report by Transparency…
Global Gastrointestinal Industry Report 2016
Global Gastrointestinal Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The analysts of the global Gastrointestinal market report have taken on the challenge of procuring insightful data from reliable resources and precisely segregating critical market dynamics, given the voluminous amount of information available. Established and novice players in the Gastrointestinal market can secure their position on the cutting edge…
